Accuracy of manual QRS duration assessment: Its importance in patient selection for cardiac resynchronization and implantable cardioverter defibrillator therapy

Europace

Volumn 11, Issue 5, 2009, Pages 638-642

  Tomlinson, David R ^a   Bashir, Yaver ^a   Betts, Timothy R ^a   Rajappan, Kim ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Cardiac resynchronization therapy; Electrocardiogram; Implantable cardioverter defibrillator; QRS duration

Indexed keywords

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOLOGIST; CONSENSUS; DEFIBRILLATOR; ELECTROCARDIOGRAM; HUMAN; OBSERVER VARIATION; PATIENT ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; QRS COMPLEX; SYSTOLIC DYSFUNCTION;

EID: 66749105276     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eup001     Document Type: Article

References (23)

1. Shenkman HJ, Pampati V, Khandelwal AK, McKinnon J, Nori D, Kaatz S et al. Congestive heart failure and QRS duration: establishing prognosis study. Chest 2002; 122:528–34.
2. Kalra PR, Sharma R, Shamim W, Doehner W, Wensel R, Bolger AP et al. Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS duration. Int J Cardiol 2002;86:225–31.
3. Iuliano S, Fisher SG, Karasik PE, Fletcher RD, Singh SN. QRS duration and mortality in patients with congestive heart failure. Am Heart J 2002;143:1085–91.
4. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873–80.
5. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539–49.
6. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140–50.
7. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337:1576–83.
8. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of anti-arrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:748–54.
9. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS et al. Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297–302.
10. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877–83.
11. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225–37.
12. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004;350:2151–8.
13. Cardiac resynchronisation therapy for the treatment of heart failure: NICE Technology appraisal guidance 120. www.nice.org.uk/TA120 (2007).
14. Implantable Cardioverter Defibrillators for Arrhythmias: NICE Technology appraisal guidance 95. www.nice.org.uk/TA095 (January 2006).
15. Radford MJ, Arnold JM, Bennett SJ, Cinquegrani MP, Cleland JG, Havranek EP et al. ACC/AHA key data elements definitions for measuring the clinical management outcomes of patients with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Heart Failure Clinical Data Standards): developed in collaboration with the American College of Chest Physicians the International Society for Heart Lung Transplantation: endorsed by the Heart Failure Society of America. Circulation 2005;112:1888–916.
16. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS et al. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008;117:e350–408.
17. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933–40.
18. Gasparini M, Regoli F, Galimberti P, Ceriotti C, Bonadies M, Mangiavacchi M et al. Three years of cardiac resynchronization therapy: could superior benefits be obtained in patients with heart failure and narrow QRS? Pacing Clin Electrophysiol 2007;30:S34–9.
19. Bleeker GB, Holman ER, Steendijk P, Boersma E, van der Wall EE, Schalij MJ et al. Cardiac resynchronization therapy in patients with a narrow QRS complex. J Am Coll Cardiol 2006;48:2243–50.
20. Yu CM, Chan YS, Zhang Q, Yip GW, Chan CK, Kum LC et al. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography. J Am Coll Cardiol 2006;48: 2251–7.
21. Beshai JF, Grimm RA, Nagueh SF, Baker JH III, Beau SL, Greenberg SM et al. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med 2007;357:2461–71.
22. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005;112: e154–235.
23. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al. ACC/ AHA/ESC 2006 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e385–484.